Therapeutic Angiogenesis and Cardiovascular Disease: A Review

Area of Science:

• Cardiovascular Research
• Angiogenesis Therapeutics
• Translational Medicine

Background:

• Novel angiogenesis inhibitors have shown success in cancer therapy.
• Research shifted towards angiogenesis promotors for peripheral and coronary artery diseases.
• Early animal models demonstrated promising results for therapeutic angiogenesis.

Purpose of the Study:

• To review the historical investigation of therapeutic angiogenesis for cardiovascular disease.
• To discuss the challenges and lessons learned from clinical trials.
• To explore future directions in the field.

Main Methods:

• Literature review of randomized control trials and preclinical studies.
• Analysis of the translation from animal models to human clinical outcomes.
• Synthesis of historical data to identify key challenges.

Main Results:

• Numerous randomized control trials failed to yield meaningful clinical benefits.
• The translation of promising preclinical findings to effective patient treatments was unsuccessful.
• Significant discrepancies exist between animal model outcomes and human clinical results.

Conclusions:

• Therapeutic angiogenesis for cardiovascular disease has faced significant translational hurdles.
• Lessons learned emphasize the complexity of vascularization in human disease.
• Future research requires innovative approaches beyond traditional angiogenesis promotion.